Qiagen N.V. (QGEN) Shares are Up 4.82%

Qiagen N.V. (QGEN) : Traders are bullish on Qiagen N.V. (QGEN) as it has outperformed the S&P 500 by a margin of 2.86% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.18%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 4.82% in the last 1 week, and is up 9.8% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

Qiagen N.V. (NASDAQ:QGEN): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $22.88 and $22.82 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $23.21. The buying momentum continued till the end and the stock did not give up its gains. It closed at $23.07, notching a gain of 1.23% for the day. The total traded volume was 1,201,688 . The stock had closed at $22.79 on the previous day.


The stock has recorded a 20-day Moving Average of 5.44% and the 50-Day Moving Average is 6.42%. Qiagen NV has dropped 3.31% during the last 3-month period . Year-to-Date the stock performance stands at -16.56%.

QIAGEN N.V. (QIAGEN) is a Netherlands-based holding company. The Company and its subsidiaries are engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Sample to Insight solutions are composed of sample and assay technologies, bioinformatics and automation systems. Sample to Insight molecular technologies are applicable across a range of applications and customer classes through more than 500 core consumable products, as well as instruments that automate the use of these products for sample preparation, analysis and interpretation. The Companys bioinformatics solutions connect laboratory workflows and process amounts of genomic data, enabling scientists or clinicians to interpret results and decide on further action.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *